Concerto and Sacco System sign development and commercialization agreement
Concerto Biosciences and Sacco System agreed to develop and commercialize microbial ingredients for food, nutrition and related applications.
Evidence notes
- The programme combines Concerto’s kChip and kAI discovery platform with Sacco System’s development and production capabilities.
- Work targets next-generation microbial ingredients.
- The agreement spans discovery, development and commercialization.